Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
As of April 22, 2026, it was removed from FDA Category 2, but the FDA's Pharmacy Compounding Advisory Committee will not consider it for the 503A bulks list until the July 23, 2026 meeting
doses over ~1 mg/day are not associated with added benefit
In vitro studies demonstrate that BPC-157 promotes survival of cells exposed to various stressors including oxidative damage, toxic substances, and serum deprivation
Protect yourself from light
However, human safety data beyond 12 weeks doesn't exist
US$ 21.34
US$ 26.83
US$ 20.74
